학술논문

Comparable safety and non-inferior immunogenicity of the SARS-CoV-2 mRNA vaccine candidate PTX-COVID19-B and BNT162b2 in a phase 2 randomized, observer-blinded study
Document Type
Article
Source
In: Scientific Reports. (Scientific Reports, December 2024, 14(1))
Subject
Language
English
ISSN
20452322